STTK

$0.00

(

+0.00%

)
Quote details

stock

Shattuck Labs Inc

NASDAQ | STTK

1.98

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 17, 2025)

$118.97M

Market Cap

-

P/E Ratio

-0.99

EPS

$2.70

52 Week High

$0.69

52 Week Low

HEALTHCARE

Sector

STTK Chart

Recent Chart
Price Action

STTK Technicals

Tags:

STTK Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $5.7M
Total Revenue $5.7M
Cost Of Revenue $3.8M
Costof Goods And Services Sold $3.8M
Operating Income -$81M
Selling General And Administrative $19M
Research And Development $67M
Operating Expenses $86M
Investment Income Net -
Net Interest Income $5.2M
Interest Income $5.2M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.8M
Income Before Tax -$75M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$75M
Comprehensive Income Net Of Tax -
Ebit -$81M
Ebitda -$77M
Net Income -$75M

Revenue & Profitability

Earnings Performance

STTK Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $91M
Total Current Assets $79M
Cash And Cash Equivalents At Carrying Value $57M
Cash And Short Term Investments $57M
Inventory -
Current Net Receivables -
Total Non Current Assets $12M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $16M
Other Current Assets $6.2M
Other Non Current Assets -
Total Liabilities $11M
Total Current Liabilities $8.9M
Current Accounts Payable $2.4M
Deferred Revenue -
Current Debt -
Short Term Debt $900K
Total Non Current Liabilities $2.5M
Capital Lease Obligations $3.4M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $3.4M
Other Current Liabilities $5.6M
Other Non Current Liabilities -
Total Shareholder Equity $80M
Treasury Stock -
Retained Earnings -$382M
Common Stock $5K
Common Stock Shares Outstanding $51M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$61M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $3.8M
Capital Expenditures $59K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$8.5M
Cashflow From Financing $787K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$17K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$75M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $5.7M
Total Revenue $5.7M
Cost Of Revenue $3.8M
Costof Goods And Services Sold $3.8M
Operating Income -$81M
Selling General And Administrative $19M
Research And Development $67M
Operating Expenses $86M
Investment Income Net -
Net Interest Income $5.2M
Interest Income $5.2M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.8M
Income Before Tax -$75M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$75M
Comprehensive Income Net Of Tax -
Ebit -$81M
Ebitda -$77M
Net Income -$75M

STTK News

STTK Profile

Shattuck Labs Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Shattuck Labs, Inc. is a clinical-stage biotechnology firm headquartered in Austin, Texas, specializing in the development of innovative therapies for cancer and autoimmune diseases. Utilizing its proprietary technology platforms, the company focuses on creating targeted treatments that address critical unmet medical needs in the healthcare landscape. With a robust commitment to research and development, Shattuck Labs aims to significantly enhance patient outcomes by delivering next-generation therapeutics, positioning itself as a competitive player in the biopharmaceutical industry.

WTO
+25.52%
$0.03
LPTX
+368.57%
$2.05
APLT
+30.18%
$0.28
AMIX
+58.18%
$1.15
KXIN
-7.64%
$0.28
NVDA
-1.87%
$186.60
ONDS
-12.88%
$6.25
CHR
-2.66%
$0.04
ASST
-3.70%
$1.04
TSLA
+1.13%
$408.92
GLMD
+0.96%
$1.05
PFE
+0.07%
$25.08
SOFI
-2.80%
$27.04
DVLT
+1.91%
$1.86
F
-2.35%
$12.88
PLUG
-7.12%
$2.08
INTC
-2.28%
$34.71
GNS
-9.87%
$0.77
QUBT
+8.49%
$11.50
ACHR
-5.83%
$7.42
VHAI
-25.00%
$0.00
AXDX
-61.36%
$0.03
DNN
-3.62%
$2.39
BYND
-3.70%
$1.04
BITF
+3.48%
$2.67
AMZN
-0.77%
$232.87
BMNR
-10.02%
$30.95
RIVN
-1.58%
$14.87
ETHD
+8.79%
$5.69
DFLI
-1.27%
$0.80
ASBP
-14.11%
$0.09
KVUE
-2.52%
$16.24
MARA
-4.00%
$11.51
NIO
-1.29%
$6.08
GOOGL
+3.11%
$285.02
ADAP
-15.14%
$0.05
SNAP
-4.55%
$8.18
HPE
-7.00%
$21.23
PLTR
-1.58%
$171.25
BURU
-13.34%
$0.21
RIG
+1.74%
$4.08
TLRY
-4.62%
$1.03
AAPL
-1.81%
$267.46
GPUS
-14.84%
$0.23
CIFR
-0.06%
$14.35
AAL
-3.29%
$12.34
RGTI
-3.10%
$24.69
GRAB
-1.47%
$5.33
WULF
+0.54%
$11.05
HOOD
-5.33%
$115.97
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
AMD
-2.54%
$240.52
MSPR
+18.40%
$0.53
PLTD
+1.75%
$6.96
WBD
-1.25%
$22.74
BAC
-2.14%
$51.48
BTG
-2.68%
$3.99
CAN
-4.37%
$0.85
XPEV
-10.31%
$22.43
SRM
+53.27%
$10.30
T
-0.46%
$25.47
GOOG
+3.11%
$285.60
IREN
+2.24%
$47.41
NOK
-1.04%
$6.66
SMCI
-6.37%
$34.10
BBD
-1.63%
$3.62
AMC
-4.82%
$2.17
BTBT
-4.56%
$2.30
HBAN
-2.73%
$15.30
HIMS
-3.78%
$35.58
MU
-1.97%
$241.95
QBTS
-3.30%
$22.83
BTE
-4.43%
$3.02
OWL
-5.81%
$13.77
SOUN
-6.08%
$11.43
CRWV
-2.62%
$75.33
CSCO
-0.28%
$77.78
WLGS
-5.57%
$0.04
IONZ
-3.07%
$5.04
CLSK
-3.19%
$10.61
VALE
-1.05%
$12.17
MTSR
-0.35%
$70.50
TWOH
+4.16%
$0.00
NFLX
-0.83%
$110.29
EOSE
-5.79%
$13.00
ABEV
-0.39%
$2.54
APLD
-3.02%
$22.93
RXRX
-0.48%
$4.12
CLF
+2.23%
$10.97
SMR
-6.19%
$21.06
IVVD
+20.85%
$2.84
CRCL
-6.47%
$76.59
AFMD
-34.94%
$0.18
AMCR
-0.35%
$8.45
QS
-3.57%
$12.95
KDP
-0.62%
$26.96
NBIS
+2.92%
$85.98
JOBY
-3.60%
$13.89
WTO
+25.52%
$0.03
LPTX
+368.57%
$2.05
APLT
+30.18%
$0.28
AMIX
+58.18%
$1.15
KXIN
-7.64%
$0.28
NVDA
-1.87%
$186.60
ONDS
-12.88%
$6.25
CHR
-2.66%
$0.04
ASST
-3.70%
$1.04
TSLA
+1.13%
$408.92
GLMD
+0.96%
$1.05
PFE
+0.07%
$25.08
SOFI
-2.80%
$27.04
DVLT
+1.91%
$1.86
F
-2.35%
$12.88
PLUG
-7.12%
$2.08
INTC
-2.28%
$34.71
GNS
-9.87%
$0.77
QUBT
+8.49%
$11.50
ACHR
-5.83%
$7.42
VHAI
-25.00%
$0.00
AXDX
-61.36%
$0.03
DNN
-3.62%
$2.39
BYND
-3.70%
$1.04
BITF
+3.48%
$2.67
AMZN
-0.77%
$232.87
BMNR
-10.02%
$30.95
RIVN
-1.58%
$14.87
ETHD
+8.79%
$5.69
DFLI
-1.27%
$0.80
ASBP
-14.11%
$0.09
KVUE
-2.52%
$16.24
MARA
-4.00%
$11.51
NIO
-1.29%
$6.08
GOOGL
+3.11%
$285.02
ADAP
-15.14%
$0.05
SNAP
-4.55%
$8.18
HPE
-7.00%
$21.23
PLTR
-1.58%
$171.25
BURU
-13.34%
$0.21
RIG
+1.74%
$4.08
TLRY
-4.62%
$1.03
AAPL
-1.81%
$267.46
GPUS
-14.84%
$0.23
CIFR
-0.06%
$14.35
AAL
-3.29%
$12.34
RGTI
-3.10%
$24.69
GRAB
-1.47%
$5.33
WULF
+0.54%
$11.05
HOOD
-5.33%
$115.97
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
AMD
-2.54%
$240.52
MSPR
+18.40%
$0.53
PLTD
+1.75%
$6.96
WBD
-1.25%
$22.74
BAC
-2.14%
$51.48
BTG
-2.68%
$3.99
CAN
-4.37%
$0.85
XPEV
-10.31%
$22.43
SRM
+53.27%
$10.30
T
-0.46%
$25.47
GOOG
+3.11%
$285.60
IREN
+2.24%
$47.41
NOK
-1.04%
$6.66
SMCI
-6.37%
$34.10
BBD
-1.63%
$3.62
AMC
-4.82%
$2.17
BTBT
-4.56%
$2.30
HBAN
-2.73%
$15.30
HIMS
-3.78%
$35.58
MU
-1.97%
$241.95
QBTS
-3.30%
$22.83
BTE
-4.43%
$3.02
OWL
-5.81%
$13.77
SOUN
-6.08%
$11.43
CRWV
-2.62%
$75.33
CSCO
-0.28%
$77.78
WLGS
-5.57%
$0.04
IONZ
-3.07%
$5.04
CLSK
-3.19%
$10.61
VALE
-1.05%
$12.17
MTSR
-0.35%
$70.50
TWOH
+4.16%
$0.00
NFLX
-0.83%
$110.29
EOSE
-5.79%
$13.00
ABEV
-0.39%
$2.54
APLD
-3.02%
$22.93
RXRX
-0.48%
$4.12
CLF
+2.23%
$10.97
SMR
-6.19%
$21.06
IVVD
+20.85%
$2.84
CRCL
-6.47%
$76.59
AFMD
-34.94%
$0.18
AMCR
-0.35%
$8.45
QS
-3.57%
$12.95
KDP
-0.62%
$26.96
NBIS
+2.92%
$85.98
JOBY
-3.60%
$13.89

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.